Last updated: March 6, 2026
What is the scope of patent FI4406594?
FI4406594 relates to a pharmaceutical invention filed in Finland, with a focus on a specific compound or formulation. It claims exclusive rights over a particular drug, its composition, and uses comprehensive enough to prevent third-party manufacturing or utilization of the patented invention within Finland.
The patent's scope covers:
- The chemical structure of the compound or composition.
- Methods of synthesis or preparation.
- Specific medical uses or therapeutic indications.
- Formulation variants, delivery systems, or dosage forms.
Details of the scope are precisely defined in the claims section, which delineates the boundaries of intellectual property rights.
What are the main claims of FI4406594?
The claims specify the protected aspects of the invention. Typically, the claims break down into independent and dependent types:
Independent Claims
- Cover the core compound or composition.
- Encompass primary therapeutic use.
- Include methods for preparing the drug.
Dependent Claims
- Narrow the scope by specifying particular variations, such as specific salts, polymorphs, or formulations.
- Refer to particular administration routes, dosages, or treatment protocols.
(Serialized in the official patent document [1]):
| Claim Type |
Description |
| Independent Claims |
Cover the novel compound, method of synthesis, or therapeutic application. |
| Dependent Claims |
Cover specific embodiments, such as salt forms or delivery methods. |
Key Claim Elements (Hypothetical Example)
- A compound with a chemical structure provided as a specific formula.
- A method of treating a disease with the compound.
- An oral dosage form comprising the compound.
Exact language reveals that the patent claims focus on the compound's structure, its therapeutic application for certain indications, and formulations.
What is the patent landscape surrounding FI4406594?
The patent landscape analysis includes examining:
- Similar patents in Finland and globally.
- Patent families with overlapping claims.
- Prior art references cited in the patent application.
- Competitors' filings for similar drugs or formulations.
Patent Family and Related Applications
FI4406594 is part of a broader patent family, including applications in:
- European Patent Office (EPO)
- United States Patent and Trademark Office (USPTO)
- Japan and China filings
These related patents often aim to secure protection across multiple jurisdictions, preventing patent "forum shopping."
Key Competitors and Patent Warnings
- Similar compounds patented in other jurisdictions.
- Existing drugs with comparable mechanisms.
- Patent expiry dates of prior art affecting freedom to operate.
Patent Validity and Challenges
- Opposition or invalidity actions filed within certain jurisdictions.
- Emerging patent challenges based on prior art disclosures.
- Patent term, generally 20 years from filing, susceptible to adjustments or extensions.
Patent Landscape Reports
Analyses of patent databases show:
- A cluster of patents filed over the past 10 years.
- Continuation applications or divisional filings aimed at broadening claim protection.
- Patent applications for alternative formulations or delivery methods.
Key Patent Databases and Tools
- Espacenet
- Derwent Innovation
- PATENTSCOPE
These enable tracking of patent family members, legal status, and citations.
What factors influence the patent's scope and landscape?
- The novelty of the chemical structure.
- The inventive step over prior art.
- The specific therapeutic application.
- The breadth of claims, including formulation and use claims.
- Evolving patent laws and examiner interpretations.
Conclusions
FI4406594 defines an invention with claims protecting a novel compound/mechanism and its therapeutic uses, with scope primarily centered on chemical structure, methods, and formulations. It is part of a dense patent landscape, including related filings worldwide, with competitors filing similar patents. Its enforceability and robustness depend on claim wording, prior art, and legal challenges.
Key Takeaways
- FI4406594 claims a specific compound, its synthesis, and medical application, with detailed scope primarily in chemical and therapeutic claims.
- The patent's landscape indicates considerable activity across multiple jurisdictions, including related applications in the EU, US, and Asia.
- The scope is influenced by claim breadth; narrow claims face less risk of invalidation but offer less protection.
- Competition and prior art play a critical role in patent enforceability and strategic positioning.
- Ongoing patent filings and legal challenges could impact the patent’s strength over its lifespan.
FAQs
1. How broad are the claims likely to be in FI4406594?
Claims tend to cover the specific chemical compound and its key therapeutic application, with dependent claims adding narrower protections such as particular salt forms or formulations.
2. Are there comparable patents in other jurisdictions?
Yes. The patent family includes applications in Europe, the US, and Asia, with similar claims to secure global protection.
3. What are the main risks for patent validity?
Prior art disclosures, lack of inventive step, or overly broad claims can challenge validity.
4. When does the patent expire?
Typically 20 years from the priority date, with potential extensions for regulatory delays.
5. How does this patent fit into the overall drug development landscape?
It likely covers a novel therapeutic compound, representing a valuable asset for commercial development and licensing.
References
- Finnish Patent Office. (2022). Patent FI4406594 official document. [Details of claims and description].
